Bookmark

Add to MyYahoo RSS

AstraZeneca News

News on AstraZeneca (Ticker: AZN) continually updated from thousands of sources around the net.

6 hrs ago | MarketNewsVideo

Thursday's ETF Movers: BSCF, XBI

In trading on Thursday, the Guggenheim BulletShares 2015 Corporate Bond ETF is outperforming other ETFs, trading flat on the day.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Business News, Video

10 hrs ago | BioSpace

AstraZeneca PLC Steps Up Push Into Cancer Immunotherapy, Falls Behind ...

AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumor types.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry

14 hrs ago | Wall Street Journal

AstraZeneca Raises Earnings Outlook

AstraZeneca PLC raised its earnings outlook for the full year on Thursday, though net profit dipped in the second quarter, as it continues to plow investment into its new-drugs pipeline.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, AstraZeneca Group

Wed Jul 30, 2014

TheStreet.com

Why AstraZeneca (AZN) Stock Is Up Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Mozilla, Chronic Obstructive Pulmonary Disease, Health, Financial Markets, TheStreet

TheStreet.com

European Stocks Steady as Barclays Reports, AstraZeneca Buys Generic Line

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Financial Markets, Mozilla, Business News

TheStreet.com

European Stocks Steady as Barclays Reports, AstraZeneca Buys Generic Line

LONDON -- European stock indices were little changed on Wednesday as a new round of U.S. and European Union sanctions against Russia over its suspected military backing of separatists in Ukraine coincided with a slew of corporate earnings from some of Europe's biggest companies.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Financial Markets, Business News

Wall Street Journal

AstraZeneca in Respiratory Drugs Deal

AstraZeneca PLC has agreed to buy the rights to Almirall SA's respiratory drugs in a deal worth more than $2 billion.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, AstraZeneca Group

Tue Jul 29, 2014

BioSpace

AstraZeneca PLC Fights With Pediatrician Group Over Preemie Drug Guidelines

Once again, there is controversy over an expensive drug for premature babies. At issue are new American Academy of Pediatrics guidelines that recommend scaling back usage of a drug called Synagis, which costs several thousand dollars and is sold by AstraZeneca 'sAZN.LN -0.23% MedImmune unit, because evidence shows the medicine benefits few children ... (more)

Comment?

Related Topix: Pediatrics, Biotech, Medicine, Healthcare Industry, AstraZeneca Group

WNEM-TV Saginaw

Merck 2Q profit more than doubles

A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Zetia, Ezetimibe (generic), Whitehouse Station, NJ, AstraZeneca Group

Fri Jul 18, 2014

BioSpace

AstraZeneca PLC Unveils Plans For "See-Through" Labs In Cambridge

The days of secretive drug research will soon be a distant memory for the scientists at one of Britain's biggest pharma companies.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, AstraZeneca Group

Thu Jul 17, 2014

Seeking Alpha

Xalkori: Pfizer's Lung Cancer Drug Might Get A Future Boost In Sales

It is no secret that Pfizer has had a rocky first half this year. The difficulties around its attempt to acquire AstraZeneca were compounded by Q1 sales that missed market expectations by 9 percent.

Comment?

Related Topix: Medicine, Cancer, Health, Lung Cancer, Pfizer, Biotech, Healthcare Industry, AstraZeneca Group, Oncology

Wed Jul 16, 2014

GuruFocus.com

I Believe AstraZeneca Is Fairly Valued

AstraZeneca PLC , a $94.71 billion market cap company is a giant in the drug industry and has a trailing P/E ratio that indicates that the stock is relatively undervalued .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, AstraZeneca Group

Customer Interaction Solutions

Alexion Announces the Appointments of David R. Brennan, M. Michele...

Alexion Pharmaceuticals, Inc. today announced the appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to the Company's Board of Directors, effective immediately.

Comment?

Related Topix: Alexion Pharmaceuticals, Biotech, Medicine, Healthcare Industry, AstraZeneca Group, Merck , Insurance, Marsh and Mclennan Companies

Seeking Alpha

Walgreen Tax Inversion: Masking A Weak Business?

Walgreen shares are trading near an all-time high and at a fancy multiple for a drug store chain - a forward PE ratio of more than 20 - as investors focus on whether the company will engage in a tax inversion as part of its expected acquisition of the 55% of Alliance Boots, the European drug store chain, not already owned by Walgreen.

Comment?

Related Topix: Walgreens, Retail, Pfizer, Biotech, Medicine, Healthcare Industry, AstraZeneca Group, Rite Aid

Tue Jul 15, 2014

MarketWatch

U.S. 'inversion' takeovers strike fear in Europe

Bankers in Europe say their clients are concerned about being taken over by U.S. companies as the trend of so-called inversion deals continues.

Comment?

Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Shire plc

AmericanBankingNews.com

AstraZeneca plc Given Average Recommendation of "Hold" by Analysts

AstraZeneca plc has earned a consensus rating of "Hold" from the twenty-two analysts that are currently covering the stock, AnalystRatings.NET reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, AstraZeneca Group

Mon Jul 14, 2014

Seeking Alpha

Medtronic Not Sticking Around To Rearrange Chairs On The Titanic

We also think such moves implicitly reveal their company's views on the direction of future fiscal deficits in the US, and by extension, the belief that the financial burden will only increase on future generations.

Comment?

Related Topix: Walgreens, Retail, Medtronic, Medicine, Medical Equipment, Healthcare Industry, Pfizer, Biotech, AstraZeneca Group

Wed Jul 09, 2014

BioSpace

Here's Why Pfizer Inc. Should Buy GlaxoSmithKline

In the aftermath of pharmaceutical giant Pfizer failing in its repeated attempts to acquire European drug maker AstraZeneca , investors may be wondering what's next.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, AstraZeneca Group

BioSpace

AstraZeneca PLC, Max Planck Institute To Create Satellite Chemistry Unit

AstraZeneca announced an agreement with the Max Planck Institute of Molecular Physiology , Germany, to establish a "satellite unit" in cardiovascular and metabolic disease , linked to AstraZeneca's CVMD Innovative Medicines unit in Molndal, Sweden, to study new modalities chemistry.

Comment?

Related Topix: Chemistry, Science, Biotech, Medicine, AstraZeneca Group, Healthcare Industry

Tue Jul 08, 2014

BioSpace

Fund Manager Dumps Biggest Investment Into AstraZeneca PLC

Veteran life sciences investor Neil Woodford has put his money where his mouth is by choosing AstraZeneca as the single biggest investment for his new fund.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, AstraZeneca Group

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••